KYNAM CAPITAL MANAGEMENT, LP – BioCryst Pharmaceuticals, Inc. Transaction History
KYNAM CAPITAL MANAGEMENT, LP portfolio value:
$5.48M
portfolio value
KYNAM CAPITAL MANAGEMENT, LP quarter portfolio value change:
+19.09%
quarter
BioCryst Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -53.54% | -501.44K shares | -4.42M | $12.6 | 435.11K |
| Q2 2022 | share | Increase | 0.00% | 936.56K shares | 9.90M | $10.58 | 936.56K |